India Launches First Indigenous Antibiotic
On 20th November 2024, India's first indigenous antibiotic – Nafithromycin – developed to fight drug-resistant infections, was launched.
Key Points
- Indigenous Innovation: Nafithromycin, developed with support from the Biotechnology Industry Research Assistance Council (BIRAC) and brought to market by Wockhardt under the name Miqnaf, is the first antibiotic developed in India to combat Antimicrobial Resistance (AMR).
- Targeting Pneumonia: It is designed to treat Community-Acquired Bacterial Pneumonia (CABP), a severe illness caused by drug-resistant bacteria, particularly affecting vulnerable populations such as children, the elderly, and immunocompromised individuals.
- Efficacy: Nafithromycin is ten times more effective than existing drugs like azithromycin and offers superior safety ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Skin Health Gets Global Attention
- 2 Scientists Pioneer Ultra-Sensitive Cryo-EM with MagIC and DuSTER
- 3 Superheated Plasma
- 4 Antibiotic-Producing Thermophilic Bacteria
- 5 Axiom Mission 4 (Ax-4)
- 6 Scientists Discover Key to Delaying Female Fertility Decline
- 7 Strawberry Moon
- 8 Bharat Gen: Multilingual AI for Every Indian
- 9 India Demonstrates Quantum Entanglement-Based Secure Communication
- 10 Indigenous VTOL UAV ‘Rudrastra’
